Psoriasis can feel all-consuming, but the right strategies and support can make life more manageable when you're going ...

Johnson & Johnson said on Friday its experimental psoriasis drug met the main goal of a late-stage study, as the once-daily ...

Researchers reviewed a host of studies investigating diet plans in an effort to guide evidence-based recommendations for ...

Thomas Fuller / SOPA Images / LightRocket via Getty Images Charles River Laboratories made changes in its board and announced a strategic review as it faced pressure from Elliott Investment ...

Psoriasis is a disease that causes itchy ... Look for groups or message boards online, or ask your child's doctor about face-to-face support groups. You can also check out summer camps for ...

A new study found that 57.6% of patients with psoriasis achieved super responder status with guselkumab, characterised by complete skin clearance at week 20. Bio-naive status and lower comorbidity ...

The impact of psoriasis on quality of life goes beyond clinical measures, such as psoriasis area severity index (PASI) and ...

7. Dr. Steed’s team has disagreed with this characterization of her review. The board told her she “met or exceeded expectations” for “financial management” during her March 1 ...

Amid a chaotic biopharma ecosystem and declining revenues, Charles River Laboratories is initiating a strategic review and shaking up its board. The CRO’s board will “conduct a comprehensive ...

Elliott's Global Head of Engagement Steven Barg will join the board along with three other ... Charles River will initiate a comprehensive strategic review of its business to help push the stock ...